Listening to the people at the heart of healthcare
At GE HealthCare, we see possibilities through innovation. As a stand-alone company, GE HealthCare is a leader in precision care, infusing innovation with patient-focused technologies to enable better care. We’re dedicated to providing integrated solutions that make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier. Together, we’re living our purpose to create a world where healthcare has no limits.
Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]
Dr. Robert Bridwell, MD, Co-Founder, Chief Medical Officer, and Head Clinical Architect at Appian 360 introduced fluorinated estradiol imaging for PET CT technology and discussed its use in breast cancer patients with estrogen receptor-positive tumors. He explained that the technology allows for a more comprehensive assessment of the biology across multiple metastatic lesions, rather […]
DaTscan is a radiopharmaceutical instrument for assessing adults suspected of Parkinsonian syndrome (PS). Phillip Kuo MD, PhD and Scott Sherman, MD, Phd sheds some light on this tool. DaTscan is proficient in distinguishing essential tremors from those induced by PS, including idiopathic Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). […]
DaTscan injection scan is used for differentiating essential tremor from tremor due to Parkinsonian syndromes. It is contraindicated in patients with known hypersensitivity to the active substance and iodine. Hypersensitivity reactions and thyroid accumulation have been reported following administration of the scan. It is not established as a screening or confirmatory test or for […]
Video
Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]
Dr. Robert Bridwell, MD, Co-Founder, Chief Medical Officer, and Head Clinical Architect at Appian 360 introduced fluorinated estradiol imaging for PET CT technology and discussed its use in breast cancer patients with estrogen receptor-positive tumors. He explained that the technology allows for a more comprehensive assessment of the biology across multiple metastatic lesions, rather […]
DaTscan is a radiopharmaceutical instrument for assessing adults suspected of Parkinsonian syndrome (PS). Phillip Kuo MD, PhD and Scott Sherman, MD, Phd sheds some light on this tool. DaTscan is proficient in distinguishing essential tremors from those induced by PS, including idiopathic Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). […]
DaTscan injection scan is used for differentiating essential tremor from tremor due to Parkinsonian syndromes. It is contraindicated in patients with known hypersensitivity to the active substance and iodine. Hypersensitivity reactions and thyroid accumulation have been reported following administration of the scan. It is not established as a screening or confirmatory test or for […]
The article explores the use of DaTscan injection in SPECT brain imaging to distinguish essential tremor from tremor caused by Parkinsonian syndromes. These syndromes include Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. The injection is contraindicated for patients with known hypersensitivity to its components and may lead to thyroid accumulation. Adverse reactions […]
Cerianna PET is a diagnostic tool used with FDG PET imaging to detect estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer. It is not useful for imaging other receptors such as HER2 or PR. Tissue biopsy should be used to confirm recurrence of breast cancer and ER status by pathology. Adverse […]
Cerianna is a radiolabeled estrogen imaging agent that can detect estrogen receptor status in metastatic breast cancer. It can show the heterogeneity of estrogen receptor expression in multiple lesions within a patient. It is only useful for patients who are estrogen receptor positive and tissue biopsy should be used to confirm recurrence of breast […]
Cerianna is a radioactive diagnostic agent used with PET imaging to detect estrogen receptor positive lesions in patients with recurrent or metastatic breast cancer. It is an adjunct to biopsy and can help avoid the morbidity associated with brain biopsy. However, tissue biopsy should still be used to confirm breast cancer recurrence and […]
Vscan Air is a wireless, portable, handheld ultrasound system that helps you make clinical decisions by quickly ruling in or out a variety of conditions. Gain the power of a high-performance system in a pocket-sized solution. It’s small, lightweight and wireless, providing you with a convenient, durable and flexible ultrasound solution. With Vscan Air, […]
Vscan Extend is a pocket-sized handheld ultrasound system. It empowers healthcare professionals to make focused assessments and accelerate treatment decisions at the point of care. It fits in the palm of your hand and is easy to use like a smartphone, helping you take decisive action, refer patients quickly, optimize the course of treatment […]
GE Healthcare has developed Cerianna, a precision molecular diagnostic innovation that enables clinicians to perform high-quality, whole-body PET scans to locate ER positive lesions. It addresses the challenge of providing a precise diagnosis for metastatic breast cancer patients due to discordance. Cerianna is a first-of-its-kind imaging agent that can locate ER-positive lesions and help […]
Community Generated Content
Cerianna is a radiolabeled estrogen imaging agent that can detect estrogen receptor status in metastatic breast cancer. It can show the heterogeneity of estrogen receptor expression in multiple lesions within a patient. It is only useful for patients who are estrogen receptor positive and tissue biopsy should be used to confirm recurrence of breast […]